| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |